925940-40-5 Usage
Uses
Used in Pharmaceutical Industry:
DIMETHYL-(2-[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-AMINE is used as a key intermediate in the synthesis of pharmaceuticals for its unique chemical properties and reactivity, contributing to the development of new drugs and therapies.
Used in Agrochemical Industry:
In the agrochemical industry, DIMETHYL-(2-[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-AMINE is used as a building block in the creation of agrochemicals, such as pesticides and herbicides, due to its ability to form stable and effective compounds.
Used in Organic Synthesis:
DIMETHYL-(2-[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-AMINE is utilized as a versatile reagent in organic synthesis for its ability to form a variety of complex organic compounds, facilitating the advancement of chemical research and the production of novel materials.
Check Digit Verification of cas no
The CAS Registry Mumber 925940-40-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,5,9,4 and 0 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 925940-40:
(8*9)+(7*2)+(6*5)+(5*9)+(4*4)+(3*0)+(2*4)+(1*0)=185
185 % 10 = 5
So 925940-40-5 is a valid CAS Registry Number.
925940-40-5Relevant academic research and scientific papers
PYRAZOLE [3, 4-B] PYRIDINE RAF INHIBITORS
-
Page/Page column 93, (2009/10/22)
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
ORGANIC COMPOUNDS
-
Page/Page column 114, (2009/09/04)
Compounds of formula (I) in free or salt or solvate form, where T1, T2, X, Ra, Rb, R8 and R9 have the meanings as indicated in the specification, are useful for treating inflammatory or obstructive airways, pulmonary hypertension, pulmonary fibrosis, liver fibrosis, muscle diseases and systemic skeletal disorders. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
